Tools for GPCR drug discovery

Acta Pharmacologica Sinica

Volumn 33, Issue 3, 2012, Pages 372-384

  Zhang, Ru ^a   Xie, Xin ^a,b  

^a TONGJI UNIVERSITY   (China)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

functional assay; functional selectivity; G protein coupled receptors (GPCRs); G protein independent assay; G proteindependent assay; high content screening; high throughput screening; label free assay

Indexed keywords

G PROTEIN COUPLED RECEPTOR;

AUTOMATION; DRUG RESEARCH; DRUG TARGETING; HIGH THROUGHPUT SCREENING; HUMAN; IMAGING SYSTEM; PROTEIN ANALYSIS; PROTEIN FUNCTION; REVIEW; SECOND MESSENGER; SIGNAL TRANSDUCTION;

DRUG DISCOVERY; GTP-BINDING PROTEINS; HUMANS; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 84858121231     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2011.173     Document Type: Review

References (100)

1. Fredriksson R, Lagerstrom MC, Lundin LG, Schioth HB. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol 2003; 63: 1256-72. (Pubitemid 36627220)
2. Bourne HR, Sanders DA, McCormick F. The GTPase superfamily: conserved structure and molecular mechanism. Nature 1991; 349: 117-27. (Pubitemid 21912023)
3. Pierce KL, Premont RT, Lefkowitz RJ. Seven-transmembrane receptors. Nat Rev Mol Cell Biol 2002; 3: 639-50. (Pubitemid 34987785)
4. Lefkowitz RJ, Shenoy SK. Transduction of receptor signals by betaarrestins. Science 2005; 308: 512-7.
5. Klabunde T, Hessler G. Drug design strategies for targeting G-proteincoupled receptors. Chembiochem 2002; 3: 928-44. (Pubitemid 35189597)
6. Milligan G. Principles: extending the utility of [35S]GTP gamma S binding assays. Trends Pharmacol Sci 2003; 24: 87-90. (Pubitemid 36135882)
7. Kenakin T. Efficacy at G-protein-coupled receptors. Nat Rev Drug Discov 2002; 1: 103-10. (Pubitemid 41646517)
8. Bylund DB, Toews ML. Radioligand binding methods: practical guide and tips. Am J Physiol 1993; 265: L421-9.
9. Lefkowitz RJ, Roth J, Pastan I. Radioreceptor assay of adrenocorticotropic hormone: new approach to assay of polypeptide hormones in plasma. Science 1970; 170: 633-5.
10. Trankle C, Weyand O, Schroter A, Mohr K. Using a radioalloster to test predictions of the cooperativity model for gallamine binding to the allosteric site of muscarinic acetylcholine M(2) receptors. Mol Pharmacol 1999; 56: 962-5.
11. Glickman JF, Schmid A, Ferrand S. Scintillation proximity assays in high-throughput screening. Assay Drug Dev Technol 2008; 6: 433-55.
12. Degorce F, Card A, Soh S, Trinquet E, Knapik GP, Xie B. HTRF: Atechnology tailored for drug discovery -a review of theoretical aspects and recent applications. Curr Chem Genomics 2009; 3: 22-32.
13. Harrison C, Traynor JR. The [35S]GTPgammaS binding assay: approaches and applications in pharmacology. Life Sci 2003; 74: 489-508. (Pubitemid 37377904)
14. Ferrer M, Kolodin GD, Zuck P, Peltier R, Berry K, Mandala SM, et al. A fully automated [35S]GTPgammaS scintillation proximity assay for the high-throughput screening of Gi-linked G protein-coupled receptors. Assay Drug Dev Technol 2003; 1: 261-73.
15. Johnson EN, Shi X, Cassaday J, Ferrer M, Strulovici B, Kunapuli P. A 1536-well [35S]GTPgammaS scintillation proximity binding assay for ultra-high-throughput screening of an orphan galphai-coupled GPCR. Assay Drug Dev Technol 2008; 6: 327-37.
16. Labrecque J, Wong RS, Fricker SP. A time-resolved fluorescent lanthanide (Eu)-GTP binding assay for chemokine receptors as targets in drug discovery. Methods Mol Biol 2009; 552: 153-69.
17. Frang H, Mukkala VM, Syysto R, Ollikka P, Hurskainen P, Scheinin M, et al. Nonradioactive GTP binding assay to monitor activation of g protein-coupled receptors. Assay Drug Dev Technol 2003; 1: 275-80.
18. Engstrom M, Narvanen A, Savola JM, Wurster S. Assessing activation of the human neuropeptide FF2 receptor with a non-radioactive GTP binding assay. Peptides 2004; 25: 2099-104. (Pubitemid 39574450)
19. Leopoldo M, Lacivita E, Colabufo NA, Contino M, Berardi F, Perrone R. First structure-activity relationship study on dopamine D3 receptor agents with N-[4-(4-arylpiperazin-1-yl)butyl]arylcarboxamide structure. J Med Chem 2005; 48: 7919-22. (Pubitemid 41798423)
20. Zhang HY, Watson ML, Gallagher M, Nicolle MM. Muscarinic receptor-mediated GTP-Eu binding in the hippocampus and prefrontal cortex is correlated with spatial memory impairment in aged rats. Neurobiol Aging 2007; 28: 619-26. (Pubitemid 46282208)
21. Koval A, Kopein D, Purvanov V, Katanaev VL. Europium-labeled GTP as a general nonradioactive substitute for [35S]GTPgammaS in highthroughput G protein studies. Anal Biochem 2010; 397: 202-7.
22. Eglen RM, Singh R. Beta galactosidase enzyme fragment complementation as a novel technology for high throughput screening. Comb Chem High Throughput Screen 2003; 6: 381-7. (Pubitemid 36612357)
23. Weber M, Ferrer M, Zheng W, Inglese J, Strulovici B, Kunapuli P. A 1536-well cAMP assay for Gs-and Gi-coupled receptors using enzyme fragmentation complementation. Assay Drug Dev Technol 2004; 2: 39-49. (Pubitemid 38647415)
24. Williams C. cAMP detection methods in HTS: selecting the best from the rest. Nat Rev Drug Discov 2004; 3: 125-35. (Pubitemid 38239774)
25. Wigdal SS, Anderson JL, Vidugiris GJ, Shultz J, Wood KV, Fan F. A novel bioluminescent protease assay using engineered firefly luciferase. Curr Chem Genomics 2008; 2: 16-28.
26. Gabriel D, Vernier M, Pfeifer MJ, Dasen B, Tenaillon L, Bouhelal R. High throughput screening technologies for direct cyclic AMP measurement. Assay Drug Dev Technol 2003; 1: 291-303.
27. Berridge MJ. Inositol trisphosphate and calcium signalling. Nature 1993; 361: 315-25. (Pubitemid 23041621)
28. Liu K, Titus S, Southall N, Zhu P, Inglese J, Austin CP, et al. Comparison on functional assays for Gq-coupled GPCRs by measuring inositol monophospate-1 and intracellular calcium in 1536-well plate format. Curr Chem Genomics 2008; 1: 70-8.
29. Emkey R, Rankl NB. Screening G protein-coupled receptors: measurement of intracellular calcium using the fluorometric imaging plate reader. Methods Mol Biol 2009; 565: 145-58.
30. Zhang Y, Kowal D, Kramer A, Dunlop J. Evaluation of FLIPR calcium 3 assay kit -a new no-wash fluorescence calcium indicator reagent. J Biomol Screen 2003; 8: 571-7.
31. Eglen RM, Reisine T. Photoproteins: important new tools in drug discovery. Assay Drug Dev Technol 2008; 6: 659-71.
32. Robas NM, Fidock MD. Identification of orphan G protein-coupled receptor ligands using FLIPR assays. Methods Mol Biol 2005; 306: 17-26.
33. Hansen KB, Brauner-Osborne H. FLIPR assays of intracellular calcium in GPCR drug discovery. Methods Mol Biol 2009; 552: 269-78.
34. Cheng Z, Garvin D, Paguio A, Stecha P, Wood K, Fan F. Luciferase reporter assay system for deciphering GPCR pathways. Curr Chem Genomics 2010; 4: 84-91.
35. Fan F, Wood KV. Bioluminescent assays for high-throughput screening. Assay Drug Dev Technol 2007; 5: 127-36. (Pubitemid 46581246)
36. Salahpour A, Barak LS. Visualizing receptor endocytosis and trafficking. Methods Mol Biol 2011; 756: 311-23.
37. Zanella F, Lorens JB, Link W. High content screening: seeing is believing. Trends Biotechnol 2010; 28: 237-45.
38. Middleton RJ, Kellam B. Fluorophore-tagged GPCR ligands. Curr Opin Chem Biol 2005; 9: 517-25. (Pubitemid 41338206)
39. Hislop JN, von Zastrow M. Analysis of GPCR localization and trafficking. Methods Mol Biol 2011; 746: 425-40.
40. Taylor HD, Haskins JR, Giuliano KA. High content screening: A powerful approach to systems cell biology and drug discovery totowa. New Jersery Humana Press Inc; 2007.
41. Haasen D, Schnapp A, Valler MJ, Heilker R. G protein-coupled receptor internalization assays in the high-content screening format. Methods Enzymol 2006; 414: 121-39. (Pubitemid 44716220)
42. Hirasawa A, Tsumaya K, Awaji T, Katsuma S, Adachi T, Yamada M, et al. Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat Med 2005; 11: 90-4. (Pubitemid 40215843)
43. Luttrell LM, Lefkowitz RJ. The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals. J Cell Sci 2002; 115: 455-65. (Pubitemid 34182973)
44. Violin JD, Lefkowitz RJ. Beta-arrestin-biased ligands at seven-transmembrane receptors. Trends Pharmacol Sci 2007; 28: 416-22.
45. Bowen WP, Wylie PG. Application of laser-scanning fluorescence microplate cytometry in high content screening. Assay Drug Dev Technol 2006; 4: 209-21. (Pubitemid 43810925)
46. Eggeling C, Brand L, Ullmann D, Jager S. Highly sensitive fluorescence detection technology currently available for HTS. Drug Discov Today 2003; 8: 632-41. (Pubitemid 36809258)
47. Haasen D, Wolff M, Valler MJ, Heilker R. Comparison of G-protein coupled receptor desensitization-related beta-arrestin redistribution using confocal and non-confocal imaging. Comb Chem High Throughput Screen 2006; 9: 37-47.
48. Oakley RH, Hudson CC, Cruickshank RD, Meyers DM, Payne RE Jr, Rhem SM, et al. The cellular distribution of fluorescently labeled arrestins provides a robust, sensitive, and universal assay for screening G protein-coupled receptors. Assay Drug Dev Technol 2002; 1: 21-30.
49. Garippa RJ, Hoffman AF, Gradl G, Kirsch A. High-throughput confocal microscopy for beta-arrestin-green fluorescent protein translocation G protein-coupled receptor assays using the Evotec Opera. Methods Enzymol 2006; 414: 99-120. (Pubitemid 44716219)
50. Oakley RH, Hudson CC, Sjaastad MD, Loomis CR. The ligand-independent translocation assay: an enabling technology for screening orphan G protein-coupled receptors by arrestin recruitment. Methods Enzymol 2006; 414: 50-63. (Pubitemid 44716216)
51. Bertrand L, Parent S, Caron M, Legault M, Joly E, Angers S, et al. The BRET2/arrestin assay in stable recombinant cells: a platform to screen for compounds that interact with G protein-coupled receptors (GPCRS). J Recept Signal Transduct Res 2002; 22: 533-41. (Pubitemid 36169170)
52. Hamdan FF, Audet M, Garneau P, Pelletier J, Bouvier M. Highthroughput screening of G protein-coupled receptor antagonists using a bioluminescence resonance energy transfer 1-based betaarrestin2 recruitment assay. J Biomol Screen 2005; 10: 463-75. (Pubitemid 41233225)
53. Kamal M, Marquez M, Vauthier V, Leloire A, Froguel P, Jockers R, et al. Improved donor/acceptor BRET couples for monitoring betaarrestin recruitment to G protein-coupled receptors. Biotechnol J 2009; 4: 1337-44.
54. Barnea G, Strapps W, Herrada G, Berman Y, Ong J, Kloss B, et al. The genetic design of signaling cascades to record receptor activation. Proc Natl Acad Sci U S A 2008; 105: 64-9.
55. Doucette C, Vedvik K, Koepnick E, Bergsma A, Thomson B, Turek-Etienne TC. Kappa opioid receptor screen with the Tango beta-arrestin recruitment technology and characterization of hits with secondmessenger assays. J Biomol Screen 2009; 14: 381-94.
56. Hanson BJ, Wetter J, Bercher MR, Kopp L, Fuerstenau-Sharp M, Vedvik KL, et al. A homogeneous fluorescent live-cell assay for measuring 7-transmembrane receptor activity and agonist functional selectivity through beta-arrestin recruitment. J Biomol Screen 2009; 14: 798-810.
57. Yin H, Chu A, Li W, Wang B, Shelton F, Otero F, et al. Lipid G proteincoupled receptor ligand identification using beta-arrestin PathHunter assay. J Biol Chem 2009; 284: 12328-38.
58. Zhao X, Jones A, Olson KR, Peng K, Wehrman T, Park A, et al. A homogeneous enzyme fragment complementation-based betaarrestin translocation assay for high-throughput screening of G-protein-coupled receptors. J Biomol Screen 2008; 13: 737-47.
59. Scott CW, Peters MF. Label-free whole-cell assays: expanding the scope of GPCR screening. Drug Discov Today 2010; 15: 704-16.
60. Fang Y. Label-free cell-based assays with optical biosensors in drug discovery. Assay Drug Dev Technol 2006; 4: 583-95. (Pubitemid 46017402)
61. Fang Y, Ferrie AM, Li G. Probing cytoskeleton modulation by optical biosensors. FEBS Lett 2005; 579: 4175-80. (Pubitemid 41021808)
62. Fang Y, Li G, Ferrie AM. Non-invasive optical biosensor for assaying endogenous G protein-coupled receptors in adherent cells. J Pharmacol Toxicol Methods 2007; 55: 314-22. (Pubitemid 46436523)
63. Giaever I, Keese CR. Monitoring fibroblast behavior in tissue culture with an applied electric field. Proc Natl Acad Sci U S A 1984; 81: 3761-4. (Pubitemid 14087798)
64. Giaever I, Keese CR. Micromotion of mammalian cells measured electrically. Proc Natl Acad Sci U S A 1991; 88: 7896-900. (Pubitemid 21915262)
65. Tiruppathi C, Malik AB, Del Vecchio PJ, Keese CR, Giaever I. Electrical method for detection of endothelial cell shape change in real time: assessment of endothelial barrier function. Proc Natl Acad Sci U S A 1992; 89: 7919-23.
66. Giaever I, Keese CR. A morphological biosensor for mammalian cells. Nature 1993; 366: 591-2. (Pubitemid 24036004)
67. Zhu J, Wang X, Xu X, Abassi YA. Dynamic and label-free monitoring of natural killer cell cytotoxic activity using electronic cell sensor arrays. J Immunol Methods 2006; 309: 25-33. (Pubitemid 43190799)
68. Yu N, Atienza JM, Bernard J, Blanc S, Zhu J, Wang X, et al. Real-time monitoring of morphological changes in living cells by electronic cell sensor arrays: an approach to study G protein-coupled receptors. Anal Chem 2006; 78: 35-43. (Pubitemid 43050137)
69. McLaughlin JN, Shen L, Holinstat M, Brooks JD, Dibenedetto E, Hamm HE. Functional selectivity of G protein signaling by agonist peptides and thrombin for the protease-activated receptor-1. J Biol Chem 2005; 280: 25048-59. (Pubitemid 40934596)
70. Peters MF, Vaillancourt F, Heroux M, Valiquette M, Scott CW. Comparing label-free biosensors for pharmacological screening with cell based functional assays. Assay Drug Dev Technol 2010; 8: 219-27.
71. Leung G, Tang HR, McGuinness R, Verdonk E, Michelotti JM, Liu VF. Cellular dielectric spectroscopy: A label-free technology for drug discovery. J Lab Autom 2005; 10: 258-69. (Pubitemid 41149381)
72. Dodgson K, Gedge L, Murray DC, Coldwell M. A 100K well screen for a muscarinic receptor using the Epic label-free system -a reflection on the benefits of the label-free approach to screening seventransmembrane receptors. J Recept Signal Transduct Res 2009; 29: 163-72.
73. Tran E, Ye F. Duplexed label-free G protein-coupled receptor assays for high-throughput screening. J Biomol Screen 2008; 13: 975-85.
74. Ciambrone GJ, Liu VF, Lin DC, McGuinness RP, Leung GK, Pitchford S. Cellular dielectric spectroscopy: a powerful new approach to labelfree cellular analysis. J Biomol Screen 2004; 9: 467-80.
75. Peters MF, Knappenberger KS, Wilkins D, Sygowski LA, Lazor LA, Liu J, et al. Evaluation of cellular dielectric spectroscopy, a whole-cell, label-free technology for drug discovery on Gi-coupled GPCRs. J Biomol Screen 2007; 12: 312-9. (Pubitemid 46514669)
76. McGuinness RP, Proctor JM, Gallant DL, van Staden CJ, Ly JT, Tang FL, et al. Enhanced selectivity screening of GPCR ligands using a label-free cell based assay technology. Comb Chem High Throughput Screen 2009; 12: 812-23.
77. Verdonk E, Johnson K, McGuinness R, Leung G, Chen YW, Tang HR, et al. Cellular dielectric spectroscopy: a label-free comprehensive platform for functional evaluation of endogenous receptors. Assay Drug Dev Technol 2006; 4: 609-19. (Pubitemid 46017404)
78. Lee PH, Gao A, van Staden C, Ly J, Salon J, Xu A, et al. Evaluation of dynamic mass redistribution technology for pharmacological studies of recombinant and endogenously expressed g protein-coupled receptors. Assay Drug Dev Technol 2008; 6: 83-94. (Pubitemid 351380171)
79. Fang Y, Li GG, Peng J. Optical biosensor provides insights for bradykinin B(2) receptor signaling in A431 cells. FEBS Lett 2005; 579: 6365-74.
80. Meyer BH, Segura JM, Martinez KL, Hovius R, George N, Johnsson K, et al. FRET imaging reveals that functional neurokinin-1 receptors are monomeric and reside in membrane microdomains of live cells. Proc Natl Acad Sci U S A 2006; 103: 2138-43. (Pubitemid 43271636)
81. Rozenfeld R, Devi LA. Exploring a role for heteromerization in GPCR signalling specificity. Biochem J 2011; 433: 11-8.
82. Rozenfeld R, Gupta A, Gagnidze K, Lim MP, Gomes I, Lee-Ramos D, et al. AT1R-CBR heteromerization reveals a new mechanism for the pathogenic properties of angiotensin II. EMBO J 2011; 30: 2350-63.
83. Gassmann M, Shaban H, Vigot R, Sansig G, Haller C, Barbieri S, et al. Redistribution of GABAB(1) protein and atypical GABAB responses in GABAB(2)-deficient mice. J Neurosci 2004; 24: 6086-97. (Pubitemid 38891099)
84. Rozenfeld R, Devi LA. Receptor heteromerization and drug discovery. Trends Pharmacol Sci 2010; 31: 124-30.
85. Achour L, Kamal M, Jockers R, Marullo S. Using quantitative BRET to assess G protein-coupled receptor homo-and heterodimerization. Methods Mol Biol 2011; 756: 183-200.
86. Cottet M, Albizu L, Comps-Agrar L, Trinquet E, Pin JP, Mouillac B, et al. Time resolved FRET strategy with fluorescent ligands to analyze receptor interactions in native tissues: application to GPCR oligomerization. Methods Mol Biol 2011; 746: 373-87.
87. Comps-Agrar L, Maurel D, Rondard P, Pin JP, Trinquet E, Prezeau L. Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies: application to G protein-coupled receptor oligomerization. Methods Mol Biol 2011; 756: 201-14.
88. Maurel D, Comps-Agrar L, Brock C, Rives ML, Bourrier E, Ayoub MA, et al. Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies: application to GPCR oligomerization. Nat Methods 2008; 5: 561-7. (Pubitemid 351761765)
89. Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA, et al. Crystal structure of rhodopsin: A G protein-coupled receptor. Science 2000; 289: 739-45. (Pubitemid 30650186)
90. Hanson MA, Stevens RC. Discovery of new GPCR biology: one receptor structure at a time. Structure 2009; 17: 8-14.
91. Rasmussen SG, Choi HJ, Rosenbaum DM, Kobilka TS, Thian FS, Edwards PC, et al. Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature 2007; 450: 383-7. (Pubitemid 350126755)
92. Jaakola VP, Griffith MT, Hanson MA, Cherezov V, Chien EY, Lane JR, et al. The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science 2008; 322: 1211-7.
93. Wu B, Chien EY, Mol CD, Fenalti G, Liu W, Katritch V, et al. Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science 2010; 330: 1066-71.
94. Chien EY, Liu W, Zhao Q, Katritch V, Han GW, Hanson MA, et al. Structure of the human dopamine D3 receptor in complex with a D2/ D3 selective antagonist. Science 2010; 330: 1091-5.
95. Shimamura T, Shiroishi M, Weyand S, Tsujimoto H, Winter G, Katritch V, et al. Structure of the human histamine H1 receptor complex with doxepin. Nature 2011; 475: 65-70.
96. Rasmussen SG, Devree BT, Zou Y, Kruse AC, Chung KY, Kobilka TS, et al. Crystal structure of the beta(2) adrenergic receptor-Gs protein complex. Nature 2011; 477: 549-55.
97. Sela I, Golan G, Strajbl M, Rivenzon-Segal D, Bar-Haim S, Bloch I, et al. G protein coupled receptors -in silico drug discovery and design. Curr Top Med Chem 2010; 10: 638-56.
98. Senderowitz H, Marantz Y. G Protein-Coupled Receptors: targetbased in silico screening. Curr Pharm Des 2009; 15: 4049-68.
99. Gruber CW, Muttenthaler M, Freissmuth M. Ligand-based peptide design and combinatorial peptide libraries to target G protein-coupled receptors. Curr Pharm Des 2010; 16: 3071-88.
100. Tropsha A, Wang SX. QSAR modeling of GPCR ligands: methodologies and examples of applications. Ernst Schering Found Symp Proc 2006; (2): 49-73.